midazolam has been researched along with clopidogrel in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Arı, H; Arı, S; Bozat, T; Koca, V | 1 |
Crown, N; DeGorter, MK; Dresser, GK; Gong, IY; Kim, RB; Knauer, MJ; Schwarz, UI; Suen, CM; Sugiyama, D; Tirona, RG; Woolsey, S | 1 |
1 review(s) available for midazolam and clopidogrel
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 other study(ies) available for midazolam and clopidogrel
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
[Simultaneous transcatheter treatment of perimembranous ventricular septal defect and secundum atrial septal defect in an adult: first application in Turkey].
Topics: Anesthetics, Intravenous; Clopidogrel; Echocardiography, Transesophageal; Female; Fluoroscopy; Heart Septal Defects, Atrial; Heart Septal Defects, Ventricular; Humans; Midazolam; Platelet Aggregation Inhibitors; Septal Occluder Device; Ticlopidine; Turkey; Young Adult | 2011 |
Clarifying the importance of CYP2C19 and PON1 in the mechanism of clopidogrel bioactivation and in vivo antiplatelet response.
Topics: Adolescent; Adult; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Aryldialkylphosphatase; Biotransformation; Clopidogrel; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Enzyme Inhibitors; Humans; Midazolam; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Ticlopidine; Young Adult | 2012 |